Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3983396011 | Product containing efavirenz and lamivudine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3983397019 | Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Lamivudine-containing product in oral dose form | true | Inferred relationship | Some | ||
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Tenofovir-containing product in oral dose form | true | Inferred relationship | Some | ||
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Efavirenz-containing product in oral dose form | true | Inferred relationship | Some | ||
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Efavirenz- and lamivudine- and tenofovir-containing product | true | Inferred relationship | Some | ||
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Has active ingredient | Lamivudine | true | Inferred relationship | Some | 1 | |
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Has active ingredient | Efavirenz | true | Inferred relationship | Some | 2 | |
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Has active ingredient | Tenofovir | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Efavirenz and lamivudine and tenofovir only product in oral dose form | Is a | True | Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets